Health
Insitro's AI in Drug Discovery
Insitro CEO Daphne Koller discusses the role of artificial intelligence in drug discovery during an interview with STAT News. The conversation covers advancements and challenges in this emerging field.
Coverage timeline — 1 article
STAT News
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
2026-08-26 13:46 UTC